CONTRAST-ENHANCED COLOR-CODED DOPPLER SONOGRAPHY IN MOYAMOYA DISEASE: A RETROSPECTIVE STUDY
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Woo-Keun | - |
dc.contributor.author | Choi, Chang-Woon | - |
dc.contributor.author | Kim, Chi Kyung | - |
dc.contributor.author | Oh, Kyungmi | - |
dc.date.accessioned | 2021-09-02T10:34:15Z | - |
dc.date.available | 2021-09-02T10:34:15Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2018-06 | - |
dc.identifier.issn | 0301-5629 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/75012 | - |
dc.description.abstract | The purpose of this study was to validate the feasibility of contrast-enhanced transcranial Doppler sonography (CE-TCCD) in the diagnosis of Moyamoya disease (MMD). CE-TCCD data on patients with MMD were analyzed. The CE-TCCD data were classified qualitatively into four patterns by two independent investigators: normal vascular color Doppler signal (pattern 1), augmented color Doppler signal with identifiable vascular structure (pattern 2), confluent color Doppler signal filling more than two-thirds of the display frame without identifiable vascular structure (pattern 3) and confluent color Doppler signal filling full display (pattern 4). To investigate the validity, we compared the CE-TCCD data with traditional transcranial Doppler data and Suzuki grades on cerebral angiography. A total of 32 CE-TCCD studies from 16 MMD patients (male 37.5%, median age 48) were included in this study. The CE-TCCD findings were distributed across patterns 1 (n = 3), 2 (n = 12), 3 (n = 10) and 4 (n = 7) and were correlated with the Suzuki grades (p < 0.005) and hemodynamic parameters. Inter-rater reliability was promising (Cronbach alpha = 0.883). The CE-TCCD test provides distinctive patterns in MMD, according to their stage of progression. CE-TCCD patterns seem to be a reliable and valid means for the evaluation of MMD. (C) 2018 Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject | AGENTS | - |
dc.title | CONTRAST-ENHANCED COLOR-CODED DOPPLER SONOGRAPHY IN MOYAMOYA DISEASE: A RETROSPECTIVE STUDY | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, Woo-Keun | - |
dc.contributor.affiliatedAuthor | Kim, Chi Kyung | - |
dc.contributor.affiliatedAuthor | Oh, Kyungmi | - |
dc.identifier.doi | 10.1016/j.ultrasmedbio.2018.01.002 | - |
dc.identifier.scopusid | 2-s2.0-85043780274 | - |
dc.identifier.wosid | 000430322800014 | - |
dc.identifier.bibliographicCitation | ULTRASOUND IN MEDICINE AND BIOLOGY, v.44, no.6, pp.1281 - 1285 | - |
dc.relation.isPartOf | ULTRASOUND IN MEDICINE AND BIOLOGY | - |
dc.citation.title | ULTRASOUND IN MEDICINE AND BIOLOGY | - |
dc.citation.volume | 44 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1281 | - |
dc.citation.endPage | 1285 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Acoustics | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Acoustics | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordAuthor | Moyamoya disease | - |
dc.subject.keywordAuthor | Transcranial doppler | - |
dc.subject.keywordAuthor | Ultrasound contrast agent | - |
dc.subject.keywordAuthor | Diagnosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.